21 December 2023Big PharmaMarisa Woutersen

BioNTech wins latest round in Covid-19 patent clash

CureVac suffers a blow following a favourable earlier opinion delivered by the German Federal Patent Court | Decision invalidates a patent related to mRNA tech.

Already registered?

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk

More on this story

Big Pharma

BioNTech and Pfizer challenge Moderna’s COVID-19 vaccine patent

29 August 2023 Inter partes review challenges broad claims and monopolisation over mRNA tech amidst existing legal dispute | Alnylam set to appeal separate court ruling against Moderna.

Big Pharma

Moderna, Pfizer and BioNTech hit with COVID-19 vaccine lawsuits over mRNA tech

8 June 2023 Promosome claimed it shared mRNA tech with the trio, who went on to make hugely successful vaccines | The small biotech wants a cut of more than $100 billion allegedly made by the big pharma companies.

More on this story

Big Pharma

BioNTech and Pfizer challenge Moderna’s COVID-19 vaccine patent

29 August 2023 Inter partes review challenges broad claims and monopolisation over mRNA tech amidst existing legal dispute | Alnylam set to appeal separate court ruling against Moderna.

Big Pharma

Moderna, Pfizer and BioNTech hit with COVID-19 vaccine lawsuits over mRNA tech

More on this story

Big Pharma

BioNTech and Pfizer challenge Moderna’s COVID-19 vaccine patent

29 August 2023 Inter partes review challenges broad claims and monopolisation over mRNA tech amidst existing legal dispute | Alnylam set to appeal separate court ruling against Moderna.

Big Pharma

Moderna, Pfizer and BioNTech hit with COVID-19 vaccine lawsuits over mRNA tech